Tech Blog

Chronicle Bio, Inc.

Last verified 2026-05-05. JSON

The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.

Total raised$2.2Mattributed
Latest roundFunding round, $2.2M, 2025-10-15attributed
Founded2021
HeadquartersWEST VALLEY, UT
Industrybio
Stageunknown
Websitechroniclebio.com

ChronicleBio uses large-scale human-data analysis to identify drug targets and develop disease-defining medicines. It serves pharma partners and patients with diseases that lack precise treatments. The platform turns multi-omic human data into validated targets, prioritizing biology grounded in real patient evidence rather than animal models.

Funding rounds

DateRoundAmountLead
2025-10-15Funding round$2.2Mundisclosed

Detected tech stack

Express, Google Cloud CDN, Google Cloud Load Balancing, Google Cloud, Node.js, React

Provenance

FactStatusBasis
Funding round, $2.2Mattributedsec-edgar named as publisher. No document URL on file.
Total raised $2.2Mattributedsec-edgar named as publisher. No document URL on file.
Company existenceself-reportedchroniclebio.com, read 2026-05-05
Descriptionself-reportedchroniclebio.com, read 2026-05-05

Nothing on this page is sourced yet. A sourced fact links to a document that states it.

Change history

Date
2026-09-25Latest round: seed, $2.2M, 2025-10-15 → Funding round, $2.2M, 2025-10-15, sec-edgar, No document URL on file

Records begin 2026-09-24. All changes